- Published at
- by manilatimes.net
mixed
mixed
News for Zentalis Pharmaceuticals, Inc. (ZNTL)
- Published at
- by manilatimes.net
mixedmixed- Published at
- by manilatimes.net
mixedmixed- Published at
- by gurufocus.com
negativenegativeZentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Women's Cancer
Azenosertib median duration of response (mDOR) updated to 6.3 months in the ongoing DENALI Part 1b clinical trial in patients with platinum-resistant ovarian ca- Published at
- by gurufocus.com
mixedmixedZentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, March 03, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potenti- Published at
- by benzinga.com
mixedmixedZentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Zentalis Pharma (NASDAQ:ZNTL)
SAN DIEGO, March 03, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (NASDAQ:ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for- Published at
- by gurufocus.com
positivepositiveINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zentalis Pharmaceuticals, Inc. - ZNTL
PR NewswireNEW YORK, Feb. 25, 2025 NEW YORK, Feb. 25, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zentalis Pharmac- Published at
- by insidermonkey.com
mixedmixed10 Cheapest Stocks Insiders Are Buying Recently
Why should we be interested in affordable stocks? Some investors like to look for cheaper stocks in order to diversify their portfolios, because these penny stocks often operate in different industries...- Published at
- by gurufocus.com
positivepositiveINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zentalis Pharmaceuticals, Inc. - ZNTL
PR NewswireNEW YORK, Feb. 18, 2025 NEW YORK, Feb. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zentalis Pharmac- Published at
- by gurufocus.com
positivepositiveEventide Asset Management, LLC Reduces Stake in Zentalis Pharmaceuticals Inc
On December 31, 2024, Eventide Asset Management, LLC made a significant move by reducing its stake in Zentalis Pharmaceuticals Inc. The firm decreased its holdi- Published at
- by gurufocus.com
positivepositiveMatrix Capital Management Company, LP Reduces Stake in Perimeter Solutions Inc
On December 31, 2024, Matrix Capital Management Company, LP (Trades, Portfolio) executed a strategic reduction in its holdings of Perimeter Solutions Inc (PRM).- Published at
- by manilatimes.net
mixedmixed- Published at
- by zacks.com
negativenegativeZentalis Pharmaceuticals (ZNTL) Loses -46.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
The heavy selling pressure might have exhausted for Zentalis Pharmaceuticals (ZNTL) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.- Published at
- by gurufocus.com
neutralneutralVanguard Group Inc. Reduces Stake in Zentalis Pharmaceuticals Inc.
On December 31, 2024, Vanguard Group Inc. executed a significant transaction involving Zentalis Pharmaceuticals Inc. (NASDAQ: ZNTL). The firm reduced its holdin- Published at
- by rttnews.com
mixedmixedPre-market Movers: SLXN, ZNTL, SXTP, MANH, NXT…
Israel-based Silexion Therapeutics Corp (SLXN), a biopharmaceutical company is up over 65 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.- Published at
- by seekingalpha.com
positivepositiveZentalis to cut 40% of workforce, focus on azenosertib (ZNTL:NASDAQ)
Zentalis Pharmaceuticals (ZNTL) said it plans to cut around 40% of its workforce as part of a major restructuring that will extend its cash runway into late 2027. Read more here.- Published at
- by zacks.com
positivepositiveZentalis Pharmaceuticals (ZNTL) Upgraded to Strong Buy: What Does It Mean for the Stock?
Zentalis Pharmaceuticals (ZNTL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).- Published at
- by gurufocus.com
mixedmixedZentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and devel- Published at
- by investing.com
mixedmixedZentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) By Investing.com
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)- Published at
- by gurufocus.com
mixedmixedZentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. ( ZNTL), a clinical-stage biopharmaceutical company discovering and developing c